Skip to content
Search

Latest Stories

Unnecessary closures: PDA wants 'failing pharmacies' to be taken into 'special measures control'

The Pharmaceutical Defence Association (PDA) has urged health ministers of the UK to take a strict and necessary action against the unnecessary closures of pharmacy.

Concerned over the rising number of pharmacy closures, PDA has written an open letter to health secretary Steve Barclay; Robin Swann, health minister for Northern Ireland; Eluned Morgan, minister of health and social services for Wales; and Humza Yousaf, the Scottish health secretary.


In its letter, PDA said: “The minister of health must now ensure the regulation of poor business behaviours and be prepared to take over rogue pharmacies, however large their corporate owner may be. If patients’ access to NHS services is to be protected from the consequences of avoidable full or part-day pharmacy closures.”

The association believes it is only a matter of time before serious harm to patients’ health will be caused by the decisions of mainly large chains of pharmacies to close some of their branches for all or part of a day, instead of engaging an available pharmacist to cover their agreed opening hours.

“While a small number of unforeseen closures have always occurred from time to time in pharmacies for genuine reasons, the indiscriminate scale at which closures have now become commonplace seems to have evolved over the last 20 months.”

The PDA has also noted a rapid evolution of closures as some pharmacy owners have seemingly become emboldened as no effective action or penalties to stop the closures has been taken by government, regulators, or the NHS (the main customer that commissions and funds the community pharmacy contracts).

The PDA has concluded that to protect patients, and ensure their ongoing access to pharmaceutical care, regulators in the UK should empower the Regulation and Quality Improvement Authority (RQIA) to regulate the business behaviours of companies that operate community pharmacies, including their premises, staffing levels, safety, and treatment of patients.

It's suggested an introduction a regime of financial sanctions on any businesses that breach standards and asked to provide the NHS the ultimate option to take failing pharmacies into special measures control, where the operation of that pharmacy is taken over by NHS.

Based on the actions of those who have taken commercial decisions, regardless of the potential patient impact, to unnecessarily close their branches, the PDA believes these measures are now what is required to adequately protect patients and provide communities with access to the pharmacies they rely upon.

Pharmacy closure in Scotland

Data provided to PDA in response to Freedom of Information requests in Scotland shows that the largest pharmacy businesses closed branches for full or part of days at more than 15 times the rate of other community pharmacies.

Data from NHS health boards in Scotland show that during the first five months of 2022 (1 January – 31 May) non-CCA member pharmacies reported 114 occasions across Scotland that they had to close due to unforeseen events.

“Based on the number of pharmacies owned (53 per cent non-CCA/47 per cent CCA) it would therefore be proportionate if the CCA members had reported closures due to genuine reasons on 102 full or part-day occasions during that same five-month period,” said PDA.

It added: “However, the data evidences that there were actually 1,625 reported closures of CCA member pharmacies in Scotland over that period. That means if a patients’ local pharmacy was operated by a CCA member it was more than 15 times as likely to be closed to patients for at least part of the day, than if their local pharmacy owner was a non-CCA member.”

“It is important to note that while all CCA members are headquartered in England, this data relates to Scotland only and so cannot be blamed on poor funding or previous bad policy decisions provided by NHS England. This information relates only to Scotland’s communities which are covered by the separate contract funded by Scotland’s taxpayers,” it stressed.

PDA asks information commissioner to investigate

PDA has referred NHS England to Information Commissioner over failure to share data on community pharmacy closures.

It said: “NHS England and Improvement has not been forthcoming with information requested under Freedom of Information (FOI) laws about Community Pharmacy closures, resulting in the PDA asking the Information Commissioner’s Office (ICO) to investigate.”

The PDA believe that not only does the practice of closure represent significant risk of patient harm, but it damages the reputation of pharmacy, undermines the chances of higher priority funding from governments, and discourages new entrants to the profession/existing practitioners from choosing to work in the sector.

As part of campaigning work undertaken by the PDA against unnecessary full or part-day pharmacy closure, data was requested from the NHS under the powers within the FOI Act about a range of issues including reported pharmacy closures. The association received data from each of the NHS health boards in Scotland.

“This level of information can only be identified by having the official data, and when one health board initially refused to release the information, an appeal by the PDA to the Scottish data commissioner resulted in an instruction to the health board that they must make a full disclosure as requested. Similarly, the PDA asks NHS England to share their data of reported closures as a matter of public interest,” said PDA.

It continued: “Across the UK, it is the NHS which funds the community pharmacy contracts and as it is a requirement of the NHS terms of service for community pharmacies to report each time that closures occur. Therefore many may have the reasonable expectation that the NHS would be monitoring this critical data already, as a key indicator of how their contract was being delivered.”

PDA added: "Despite multiple requests, NHS England has failed to provide the data, and therefore the PDA has been unable to carry out detailed analysis of this concerning situation to the level which has been possible for Scotland. As is appropriate when a public body fails to adequately respond to a Freedom of Information request, the PDA has escalated the matter to the Information Commissioner to investigate."

The association still hopes that NHSE will provide the data as soon as possible, hopefully before the ICO has to investigate, however if that fails to happen it will be for the ICO to determine what happens next.

More For You

Pharmacist handing medicine to patient, NHS prescription cost freeze debate

Prescription charge will remain at £9.90

Pic credit: iStock

NPA calls for end to prescription charge after freeze announcement

The National Pharmacy Association (NPA) has asked for prescription charges to be completely removed despite the government announcing today that the charge will be frozen for the first time in three years.

Patients will continue paying £9.90 to collect their medication from a pharmacy.

Keep ReadingShow less
RPS launches new prescribing development programme for pharmacists

From 2026, every newly qualified pharmacist will be an independent prescriber

gettyimages

RPS unveils new training programme to enhance pharmacists’ prescribing skills

The Royal Pharmaceutical Society (RPS) has announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

The initiative comes ahead of the NHS mandate that every newly qualified pharmacist will be an independent prescriber by 2026 — a change set to transform the future of pharmacy practice.

Keep ReadingShow less
Varenicline promotes nicotine vaping cessation in young people

Researchers warn that e-cigarette use can increase risk for nicotine addiction,uptake of combusted tobacco and other substance use.

gettyimages

Anti-smoking pill varenicline may help young people quit vaping, new study suggests

Varenicline — a daily pill already offered through NHS Stop Smoking Services — could also support young people in quitting vaping, new research has suggested.

The medication, proven to be more effective than nicotine replacement gums or patches for smoking cessation, was shown to significantly boost vaping abstinence when combined with behavioural counselling in adolescents and young adults.

Keep ReadingShow less
Relying on blue inhalers alone can worsen asthma symptoms, warns MHRA

Patients are advised to use their preventer inhaler regularly, even if their asthma feels under control.

Pic credit: gettyimages

Overuse of blue inhalers can increase risk of severe asthma attacks, warns MHRA

The Medicines and Healthcare products Regulatory Agency (MHRA) is reminding asthma patients to use their preventer (anti-inflammatory) inhalers regularly as prescribed, rather than relying solely on their blue inhalers, also referred to as reliever inhalers.

“Without regular use of a preventer inhaler, symptoms could worsen and increase the risk of severe asthma attacks,” the MHRA warned.

Keep ReadingShow less
13 pharmacists achieve RPS core advanced credential with record pass rate

The latest successful cohort includes pharmacists from both England and Scotland.

Pic credit: Getty Images

13 more pharmacists achieve RPS core advanced credential - Highest pass rate yet

The Royal Pharmaceutical Society (RPS) has announced that 13 more pharmacists have successfully completed Core Advanced Credentialling as part of the latest assessment cohort —achieving a remarkable 93% pass rate, the highest to date.

This brings the total number of pharmacists awarded the RPS core advanced credential to 113 since the launch of the Core Advanced Curriculum in 2023, with successful candidates from GP, secondary care and community settings.

Keep ReadingShow less